CCL2 and neoplasm: In addition, celecoxib has been found to reduce microglia and macrophages by inhibiting the expression of CCL2 and CXCL10 and28, in addition to its direct antitumor effects through the promotion of tumor cell apoptosis and regulation of cell cycle.